181 results
Page 3 of 10
8-K
EX-2.1
eblgdosoq52bcsjlrc
29 Mar 21
Tempest and Millendo Announce Proposed Merger Agreement
7:29am
8-K
EX-10.2
agup2g858el1i
29 Mar 21
Tempest and Millendo Announce Proposed Merger Agreement
7:29am
8-K
EX-10.1
311ehv 7i
29 Mar 21
Tempest and Millendo Announce Proposed Merger Agreement
7:29am
425
EX-10.1
ahm73d4yqy7 s5cq
29 Mar 21
Business combination disclosure
7:27am
425
EX-2.1
h1wbb
29 Mar 21
Business combination disclosure
7:27am
425
EX-10.2
0i8954e43ctw32uatj45
29 Mar 21
Business combination disclosure
7:27am
8-K
EX-1.1
dvvhv7
4 Mar 20
Entry into a Material Definitive Agreement
8:37am
8-K
EX-99.1
y9lskx5vhhw p6vtcw2
10 Feb 20
Millendo Therapeutics Appoints Christophe Arbet-Engels, MD, PhD, as Chief Medical Officer
8:42am
8-K
EX-99.1
coe 6woxd0
13 Jan 20
Results of Operations and Financial Condition
6:03am
8-K
EX-1.1
o7yi0
5 Dec 19
Millendo Therapeutics Announces Proposed Public Offering of Common Stock
4:08pm
424B5
6y6tyv58y
5 Dec 19
Prospectus supplement for primary offering
4:06pm